(CPRJ) Calamos Trust - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • • Defined Outcome
CPRJ: Options, ETFs, FLEX Options
The Calamos ETF Trust (NYSE ARCA:CPRJ) is an exchange-traded fund designed to provide defined outcome exposure to the performance of small-cap equities in the U.S. market. Under normal market conditions, the fund invests substantially all of its assets in FLexible EXchange Options (FLEX Options) that reference the price performance of the iShares® Russell 2000® ETF. FLEX Options are customized equity options that allow for precise risk management and outcome definitions, enabling the fund to deliver returns tied to specific performance parameters of the underlying ETF. The fund is non-diversified, meaning it can concentrate its investments in a limited number of securities or strategies, which may increase its volatility and risk profile compared to diversified funds.
As a defined outcome ETF, CPRJ is structured to offer investors exposure to the Russell 2000 Index, which tracks the performance of approximately 2,000 small-cap companies in the United States. The funds use of FLEX Options allows it to provide a specific risk-return profile, such as buffered losses or enhanced returns, depending on the terms of the options held. This makes it a tool for investors seeking to manage risk or capitalize on specific market conditions in the small-cap segment. The funds assets under management (AUM) total $50.34 million, and it trades with an average daily volume of 2,055 shares, indicating relatively low liquidity compared to larger ETFs.
Based on the current technical and fundamental data, the 3-month forecast for CPRJ suggests moderate volatility with a potential downside bias. The funds short-term moving averages (SMA 20 and SMA 50) are converging at 25.62, slightly above the last price of 25.19, while the SMA 200 stands at 25.30, indicating a neutral to slightly bearish trend. The average true range (ATR) of 0.09 reflects low volatility, suggesting that price movements will likely remain contained within a narrow range. Given the low trading volume and the defined outcome structure, CPRJ is expected to trade within a range of $24.80 to $26.00 over the next three months, with limited upside potential but downside protected by the buffered loss feature of its FLEX Options strategy.
Additional Sources for CPRJ ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CPRJ ETF Overview
Market Cap in USD | 49m |
Category | Defined Outcome |
TER | 0.69% |
IPO / Inception | 2024-06-28 |
CPRJ ETF Ratings
Growth 5y | 32.3% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength Industry | -1.34 |
Analysts | - |
Fair Price Momentum | 22.90 USD |
Fair Price DCF | - |
CPRJ Dividends
No Dividends PaidCPRJ Growth Ratios
Growth Correlation 3m | -22.7% |
Growth Correlation 12m | 72.7% |
Growth Correlation 5y | 72.7% |
CAGR 5y | 2.48% |
CAGR/Max DD 5y | 0.58 |
Sharpe Ratio 12m | -0.07 |
Alpha | -3.75 |
Beta | 0.31 |
Volatility | 5.80% |
Current Volume | 0.1k |
Average Volume 20d | 1.3k |
As of March 15, 2025, the stock is trading at USD 24.94 with a total of 116 shares traded.
Over the past week, the price has changed by -0.65%, over one month by -3.48%, over three months by -3.15% and over the past year by +2.48%.
Neither. Based on ValueRay Analyses, Calamos Trust is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 32.32 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CPRJ as of March 2025 is 22.90. This means that CPRJ is currently overvalued and has a potential downside of -8.18%.
Calamos Trust has no consensus analysts rating.
According to ValueRays Forecast Model, CPRJ Calamos Trust will be worth about 25.1 in March 2026. The stock is currently trading at 24.94. This means that the stock has a potential upside of +0.48%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 25.1 | 0.5% |